• J&J says no evidence darunavir works against coronavirus pharmaceutical-technology
    March 18, 2020
    Johnson and Johnson (J&J) have noted the lack of evidence that its HIV drug darunavir has antiviral activity against SARS-CoV-2, the novel coronavirus that causes Covid-19.
  • US approves Janssen’s HIV pill Symtuza pharmatimes
    July 19, 2018
    Janssen’s Symtuza has been approved US regulators as the first and only complete, darunavir-based single-tablet regimen for the treatment of HIV in adults.
PharmaSources Customer Service